Structural requirements of D-arabinose 5-phosphate isomerase (KdsD, E.C. 5.3.1.13) from Pseudomonas aeruginosa were analysed in detail using advanced NMR techniques. We performed epitope mapping studies of the binding between the enzyme and the most potent KdsD inhibitors found to date, together with studies of a set of newly synthesised arabinose 5-phosphate (A5P) mimetics. We report here the first experimental evidence that KdsD may bind the furanose form of A5P, suggesting that catalysis of ring opening may be an important part of KdsD catalysis.

Gabrielli, L., Merlo, S., Airoldi, C., Sperandeo, P., Gianera, S., Polissi, A., et al. (2014). Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY, 22, 2576-2583 [10.1016/j.bmc.2013.08.012].

Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors

GABRIELLI, LUCA;MERLO, SILVIA;AIROLDI, CRISTINA;SPERANDEO, PAOLA;GIANERA, SERENA;POLISSI, ALESSANDRA;NICOTRA, FRANCESCO;CIPOLLA, LAURA FRANCESCA
2014

Abstract

Structural requirements of D-arabinose 5-phosphate isomerase (KdsD, E.C. 5.3.1.13) from Pseudomonas aeruginosa were analysed in detail using advanced NMR techniques. We performed epitope mapping studies of the binding between the enzyme and the most potent KdsD inhibitors found to date, together with studies of a set of newly synthesised arabinose 5-phosphate (A5P) mimetics. We report here the first experimental evidence that KdsD may bind the furanose form of A5P, suggesting that catalysis of ring opening may be an important part of KdsD catalysis.
Articolo in rivista - Articolo scientifico
D-Arabinose 5-phosphate isomerase; NMR binding studies; Enzyme inhibitors; Molecular recognition; Pseudomonas aeruginosa; Escherichia coli
English
2014
22
2576
2583
none
Gabrielli, L., Merlo, S., Airoldi, C., Sperandeo, P., Gianera, S., Polissi, A., et al. (2014). Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY, 22, 2576-2583 [10.1016/j.bmc.2013.08.012].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/51441
Citazioni
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
Social impact